SFNP

January 15-17, 2020 – Toulouse, France
Scientific congress

ipna-2019-venice-1

Biomed Event

January 28, 2020 – Paris, France
Investor conference

Biomed Event	January 28, 2020	Paris, France	Investor conferences

Market Solutions Forum by ESN

March 19, 2020 – Paris, France
Investor conference

Market Solutions Forum by ESN	March 19, 2020	Paris, France	Investor conferences
Advicenne's, company dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology.

Since its founding in 2007, Advicenne has been dedicated to developing and commercializing innovative treatments that address unmet medical needs in the area of nephrology. Our lead drug candidate, ADV7103, is in late-stage clinical trials for two indications: distal renal tubular acidosis (dRTA) and cystinuria. Listed on both the Euronext Paris and Euronext Brussels stock exchanges, the company is headquartered in Nîmes, France.

Contact Us

2 + 14 =

© 2019 Advicenne